The Current Ratio as of November 2024 (TTM) for ERYTECH Pharma S.A. (ERYP) is 3.65

According to ERYTECH Pharma S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 3.65. This represents a change of 147.32% compared to the average of 1.48 of the last 4 quarters.

ERYTECH Pharma S.A. (ERYP) Historical Current Ratio (quarterly & annually)

How has ERYP Current Ratio performed in the past?

The mean historical Current Ratio of ERYTECH Pharma S.A. over the last ten years is 6.53. The current 3.65 Current Ratio has changed 5.49% with respect to the historical average. Over the past ten years (40 quarters), ERYP's Current Ratio was at its highest in in the December 2017 quarter at 16.51. The Current Ratio was at its lowest in in the September 2018 quarter at 0.

ERYTECH Pharma S.A. (ERYP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ERYTECH Pharma S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ERYTECH Pharma S.A. (ERYP) Average Current Ratio

How has ERYP Current Ratio performed in the past?

The current Current Ratio of ERYTECH Pharma S.A. (ERYP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ERYTECH Pharma S.A. (ERYP) Current Ratio vs. Peers

How is ERYP’s Current Ratio compared to its peers?

ERYTECH Pharma S.A.’s Current Ratio is less than Genfit S.A. (3.74), less than Cyteir Therapeutics, Inc. (21.89), less than Eliem Therapeutics, Inc. (60.41), greater than HCW Biologics Inc. (0.07), greater than Aptorum Group Limited (1.18), less than Surrozen, Inc. (7.40), greater than Unicycive Therapeutics, Inc. (3.61), greater than Armata Pharmaceuticals, Inc. (0.19), less than Addex Therapeutics Ltd (4.97), greater than Aceragen, Inc. (0.83), greater than Soligenix, Inc. (2.28), greater than Avenue Therapeutics, Inc. (2.67), less than Molecular Partners AG (0), less than XORTX Therapeutics Inc. (14.33), greater than Nutriband Inc. (1.40), less than Ikena Oncology, Inc. (6.57), less than Enochian Biosciences, Inc. (15.32), greater than Exicure, Inc. (0.08), greater than null (0.71),

Build a custom stock screener for ERYTECH Pharma S.A. (ERYP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ERYTECH Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ERYTECH Pharma S.A. (ERYP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ERYTECH Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.